Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Kura Oncology (KURA) Interest & Investment Income (2024 - 2025)

Historic Interest & Investment Income for Kura Oncology (KURA) over the last 2 years, with Q3 2025 value amounting to $6.3 million.

  • Kura Oncology's Interest & Investment Income rose 648.34% to $6.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $26.7 million, marking a year-over-year change of. This contributed to the annual value of $22.8 million for FY2024, which is 5520.31% up from last year.
  • According to the latest figures from Q3 2025, Kura Oncology's Interest & Investment Income is $6.3 million, which was up 648.34% from $6.9 million recorded in Q2 2025.
  • Over the past 5 years, Kura Oncology's Interest & Investment Income peaked at $7.9 million during Q1 2025, and registered a low of $5.3 million during Q1 2024.